← All trials
NCT04581473
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Oct 23, 2020
- Primary completion
- Sep 1, 2022
- Completion date
- Dec 1, 2022
- First posted
- Oct 9, 2020
- Last posted
- Nov 19, 2020
- Enrollment
- 102
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- CARsgen Therapeutics, Ltd.Lead sponsor
- Fudan UniversityOverall official - principal investigator
- Fudan UniversityCollaborator
- Chinese Academy of Medical SciencesOverall official - principal investigator
- Chinese Academy of Medical SciencesCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.